Njoku Chidi, Green Hofer Stuart, Sathyamoorthy Ganesh, Patel Neelam, Potts Henry Ww
Department of Primary Care and Public Health, Imperial College London, London, UK.
MedCity, London, UK.
Digit Health. 2023 May 24;9:20552076231173303. doi: 10.1177/20552076231173303. eCollection 2023 Jan-Dec.
Evidence-based digital health technologies are increasingly important in delivering care to an ageing population with constrained resources. In the United Kingdom, accelerator programmes (APs) have been developed to support the adoption of digital health technologies within the National Health Service. This study aims to explore the perspectives of stakeholders using APs.
Stakeholders representing nine small -and medium-sized enterprises (SMEs) that were engaged with three different APs ( = 9). Semi-structured interviews were conducted with key informants between April and September 2018. Framework analysis of the data was performed to explore their perspectives on APs.
Four key themes were generated. Informants reported the need to generate evidence before and during the programme, appreciating different types of evidence and their importance. Informants identified several key factors that were a catalyst for success, including involvement in the programme and access to individuals and organisations that were crucial for support. However, several barriers were identified at the programme and system levels. Finally, informants identified key supporting processes that enhanced the adoption of their innovations.
SMEs that develop digital health technologies report that, while APs are useful in supporting the adoption of these technologies, some issues remain. These relate to the emphasis on traditional research evidence that remains a challenge for SMEs to generate. Also, several system-level barriers to innovation in healthcare persist. As APs and SMEs continue to create an entrepreneurial ecosystem, there is increased potential for the development of supporting processes and infrastructure to accelerate the efficient and timely adoption of new digital health technologies.
基于证据的数字健康技术在为资源有限的老年人群提供护理方面日益重要。在英国，已制定加速器计划（APs）以支持国民医疗服务体系采用数字健康技术。本研究旨在探讨使用加速器计划的利益相关者的观点。
代表九家与三个不同加速器计划合作的中小企业（SMEs）的利益相关者（n = 9）。2018年4月至9月期间，对关键信息提供者进行了半结构化访谈。对数据进行框架分析，以探讨他们对加速器计划的观点。
产生了四个关键主题。信息提供者报告称，在计划之前和期间需要生成证据，认识到不同类型证据及其重要性。信息提供者确定了几个成功的关键因素，包括参与计划以及接触对支持至关重要的个人和组织。然而，在计划和系统层面发现了一些障碍。最后，信息提供者确定了增强其创新采用的关键支持流程。
开发数字健康技术的中小企业报告称，虽然加速器计划在支持这些技术的采用方面很有用，但仍存在一些问题。这些问题与对传统研究证据的强调有关，这对中小企业来说仍然是一个挑战。此外，医疗保健创新的几个系统层面障碍仍然存在。随着加速器计划和中小企业继续创建创业生态系统，开发支持流程和基础设施以加速高效及时采用新数字健康技术的潜力增加。
